These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model. Takama Y; Miyagawa S; Yamamoto A; Firdawes S; Ueno T; Ihara Y; Kondo A; Matsunami K; Otsuka H; Fukuzawa M Transpl Immunol; 2011 Jul; 25(1):49-55. PubMed ID: 21515370 [TBL] [Abstract][Full Text] [Related]
31. Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506. Yamagami S; Isobe M; Yamagami H; Hori J; Tsuru T Transplantation; 1997 Jul; 64(1):42-8. PubMed ID: 9233699 [TBL] [Abstract][Full Text] [Related]
32. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900 [TBL] [Abstract][Full Text] [Related]
33. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242 [TBL] [Abstract][Full Text] [Related]
34. Prolonged survival of rat skin allograft by treatment with FK506 ointment. Fujita T; Takahashi S; Yagihashi A; Jimbow K; Sato N Transplantation; 1997 Sep; 64(6):922-5. PubMed ID: 9326422 [TBL] [Abstract][Full Text] [Related]
35. Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection. Aharoni R; Yussim A; Sela M; Arnon R Int Immunopharmacol; 2005 Jan; 5(1):23-32. PubMed ID: 15589456 [TBL] [Abstract][Full Text] [Related]
36. Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis. Kilmartin DJ; Forrester JV; Dick AD Ocul Immunol Inflamm; 1998 Jun; 6(2):101-9. PubMed ID: 9689640 [TBL] [Abstract][Full Text] [Related]
37. [Limb allograft in rats: studies on optimal maintenance dose of FK506 and development of graft-versus-host-disease (GVHD)]. Weigao C Fukuoka Igaku Zasshi; 1996 Sep; 87(9):197-205. PubMed ID: 8913057 [TBL] [Abstract][Full Text] [Related]
38. Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty. Fei WL; Chen JQ; Yuan J; Quan DP; Zhou SY J Ocul Pharmacol Ther; 2008 Apr; 24(2):235-44. PubMed ID: 18321198 [TBL] [Abstract][Full Text] [Related]
39. A comparative investigation of FK506 and cyclosporin A in murine corneal transplantation. Reis A; Reinhard T; Sundmacher R; Braunstein S; Godehardt E Graefes Arch Clin Exp Ophthalmol; 1998 Oct; 236(10):785-9. PubMed ID: 9801895 [TBL] [Abstract][Full Text] [Related]
40. Effects of bucillamine and antigen-presenting cells in experimental autoimmune uveitis in rats. Sawa K; Mochizuki M Jpn J Ophthalmol; 1997; 41(6):388-95. PubMed ID: 9509306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]